Tilray Brands, Inc. ( NASDAQ: TLRY) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Thank you for joining today's conference call to discuss Tilray Brands' financial results for the first quarter ...
Advances in MM management have improved survival, but challenges remain for patients progressing after three therapy lines. New therapies like CAR T-cell and bispecific antibodies require integration ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果